Market closedNon-fractional
Elevance Health/ELV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Ticker
ELV
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Indianapolis, United States
Employees
104,900
Website
www.elevancehealth.com
Elevance Health Metrics
BasicAdvanced
$119B
Market cap
18.05
P/E ratio
$28.47
EPS
0.85
Beta
$6.22
Dividend rate
1.21%
Dividend yield
Price and volume
Market cap
$119B
Beta
0.85
Dividend rate
$6.22
Financial strength
Current ratio
1.489
Quick ratio
1.322
Long term debt to equity
58.068
Total debt to equity
65.456
Dividend payout ratio (TTM)
21.69%
Interest coverage (TTM)
9.92%
Management effectiveness
Return on assets (TTM)
5.89%
Return on equity (TTM)
16.58%
Valuation
Price to earnings (TTM)
18.055
Price to revenue (TTM)
0.699
Price to book
2.82
Price to tangible book (TTM)
20.61
Price to free cash flow (TTM)
146.436
Dividend yield (TTM)
1.21%
Growth
Revenue change (TTM)
3.62%
Earnings per share change (TTM)
8.35%
3-year revenue growth (CAGR)
9.94%
3-year earnings per share growth (CAGR)
18.99%
3-year dividend per share growth (CAGR)
14.35%
What the Analysts think about Elevance Health
Analyst Ratings
Majority rating from 23 analysts.
Elevance Health Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$43B
-0.16%
Net income
$2.2B
162.38%
Profit margin
5.27%
163.50%
Elevance Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$9.04
$8.99
$5.62
$10.64
-
Expected
$8.80
$8.44
$5.64
$10.53
$10.02
Surprise
2.77%
6.52%
-0.41%
1.03%
-
Elevance Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
Sept
10
Elevance Health
Dividend·Ex-dividend
Sept
25
Elevance Health
Dividend·Payment
$1.63
Per share
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $119B as of July 27, 2024.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 18.05 as of July 27, 2024.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $6.22 and the yield is 1.21%. Elevance Health has a payout ratio of 21.69% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment is scheduled for September 25, 2024.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Elevance Health stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.